rs72631830

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The ENST00000630388.2(MIR325HG):​n.411+1786G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 384,739 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000011 ( 0 hom. 2 hem. )

Consequence

MIR325HG
ENST00000630388.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.15

Publications

0 publications found
Variant links:
Genes affected
MIR325HG (HGNC:50346): (MIR325 host gene)
MIR325 (HGNC:31768): (microRNA 325) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BS2
High Hemizygotes in GnomAdExome4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR325NR_029905.1 linkn.12G>T non_coding_transcript_exon_variant Exon 1 of 1
MIR325HGNR_110400.2 linkn.306+8737G>T intron_variant Intron 1 of 3
MIR325HGNR_110401.2 linkn.411+1786G>T intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIR325HGENST00000630388.2 linkn.411+1786G>T intron_variant Intron 2 of 3 1
MIR325ENST00000385260.1 linkn.12G>T non_coding_transcript_exon_variant Exon 1 of 1 6
MIR325HGENST00000626742.1 linkn.381+1786G>T intron_variant Intron 2 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.0000268
AC:
3
AN:
111812
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000976
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000221
AC:
4
AN:
180791
AF XY:
0.0000298
show subpopulations
Gnomad AFR exome
AF:
0.000153
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000110
AC:
3
AN:
272927
Hom.:
0
Cov.:
0
AF XY:
0.0000185
AC XY:
2
AN XY:
108375
show subpopulations
African (AFR)
AF:
0.000120
AC:
1
AN:
8364
American (AMR)
AF:
0.00
AC:
0
AN:
28717
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8688
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9755
South Asian (SAS)
AF:
0.0000502
AC:
2
AN:
39879
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
24316
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1784
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
139130
Other (OTH)
AF:
0.00
AC:
0
AN:
12294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000268
AC:
3
AN:
111812
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33990
show subpopulations
African (AFR)
AF:
0.0000976
AC:
3
AN:
30749
American (AMR)
AF:
0.00
AC:
0
AN:
10545
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2639
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3558
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2661
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6083
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53143
Other (OTH)
AF:
0.00
AC:
0
AN:
1510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000302

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
15
DANN
Benign
0.84
PhyloP100
1.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72631830; hg19: chrX-76225915; API